Skip to content

Quality of Life of Colorectal Cancer Screenees in the Period Between Colonoscopy and Next Clinic Visit for Final Report: Does Real-time Endoscopic Optical Diagnosis Improve Their Quality of Life

Quality of Life of Colorectal Cancer Screenees in the Period Between Colonoscopy and Next Clinic Visit for Final Report: Does Real-time Endoscopic Optical Diagnosis Improve Their Quality of Life

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04684355
Enrollment
200
Registered
2020-12-24
Start date
2020-12-22
Completion date
2021-12-30
Last updated
2020-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Colonoscopy, Colorectal Neoplasms, Mass Screening, Quality of Life

Keywords

Colorectal Neoplasms, Colonoscopy, Quality of Life, Mass Screening, Anxiety

Brief summary

Colorectal cancer screening program has been proven to reduce colorectal cancer (CRC) mortality and is cost-effective. It has been adopted by most countries in the world, and colonoscopy is regarded as the most accurate test for detecting colorectal neoplasm. After screenees underwent colonoscopy, most endoscopists do not routinely explain the preliminary optical diagnosis to the subjects before they going home, which may cause unnecessary anxiety and may reduce the quality of life of the subjects before acquiring the final results. In recent years, endoscopic optical diagnostic technology has been validated by meta-analysis studies as an excellent tool to predict the histology of colorectal polyps and to differentiate the invasion depth of colorectal cancer. The real time feature of endoscopic optical diagnosis allows endoscopists to explain the preliminary results confidently to the subjects immediately after colonoscopy, which is expected to reduce the anxiety of the subjects before they acquired the final results and improve their quality of life. We designed a randomized controlled trial to validate whether real-time endoscopic optical diagnosis could decrease the anxiety burden and improve the quality of life for colorectal-cancer screenees after colonoscopy.

Interventions

OTHERReal-time colonoscopic optical diagnosis for colorectal neoplasm

Colonoscopic optical diagnosis by image enhanced technology has been validated as an excellent tool to predict the histology of colorectal polyps and to differentiate the invasion depth of colorectal cancer.

Sponsors

Fu Jen Catholic University Hospital
CollaboratorOTHER
Fu Jen Catholic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients who preparing to received screening or surveillance colonoscopy under general anesthesia. * Patients who preparing to received sedated colonoscopy due to other GI tract related symptoms.

Exclusion criteria

* Impaired mental status that could not understand the questionnaire questions. * Patients with major psychological disorders.

Design outcomes

Primary

MeasureTime frameDescription
Quality of life degree2 weeksUse WHOQOL-BREF Taiwanese version to measure the quality of life between the two study arms.

Secondary

MeasureTime frameDescription
Anxiety and depression degree2 weeksUse Hospital Anxiety and Depression Scale (HADS) Taiwanese version to measure the anxiety and depression degree between the two study arms.

Countries

Taiwan

Contacts

Primary ContactChen-Ya Kuo, MD
b9402039@gmail.com+886975701515

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026